Concerns are rising over less benefits in minor disease

Published: 2007-04-25 06:59:00

Updated: 2007-04-25 06:59:00

The government's plan to lower health insurance benefits for treatment of minor diseases, such as common cold, from August has sparked a concern that the plan will significantly reduce the number of prescriptions, despite some optimistic views on the activation of OTC sales in the community pharm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK